Physician profile
Christopher Bryce Johnson
NPI 1619330289
$7,044.08
in general payments reported to CMS, 2019-2025
7 companies · $6,266 in 2025
The $6,266 reported for 2025 was more than what 95% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $254 · 2023: $89.17 · 2024: $179 · 2025: $6,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,080 · Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,080.00 |
| Food and Beverage | $453.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,080.00 | 2025 | Imfinzi |
| Novocure INC. | $309.18 | 2021-2025 | Optune Lua (Novottf-200t) |
| Progenics Pharmaceuticals, INC. | $179.63 | 2022-2023 | Pylarify |
| Palette Life Sciences, INC. | $163.31 | 2022 | |
| Teleflex LLC | $142.95 | 2024-2025 | Barrigel |
| Janssen Scientific Affairs, LLC | $110.75 | 2021 | |
| Bioprotect Medical, INC. | $58.26 | 2024 | Bioprotect Balloon Implant System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.